A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Solid Tumor|High-Risk Cancer|Breast Cancer|Gastrointestinal Cancer|Gynecological Malignancies|Myelosuppression
Interventions: DRUG: Empegfilgrastim
Sponsor: Moscow Clinical Scientific Center